17.09.2019
- South Korea’s JW Pharmaceutical has picked up a 35,000-square-meter production facility in Vietnam once owned by US pharma Valeant as part of a plan to target emerging markets...
05.01.2018
- Pershing Square, the hedge fund of US activist investor Bill Ackman, and Canada-based drugmaker Valeant Pharmaceuticals have agreed in principle to pay $290 million to settle two...
15.06.2017
- Canada-based, US-run drugmaker Valeant has agreed to sell its iNova Pharmaceuticals subsidiary for $930 million in cash to a company jointly owned by funds advised and managed by...
30.03.2017
- Former Valeant CEO Michael Pearson has filed suit in a district court in the US state of New Jersey against his employer, the Canada-headquartered, US-managed drugmaker. The...
15.03.2017
- US activist investor Bill Ackman is pulling the plug on his Pershing Square Capital Management hedge fund’s loss-making engagement in drugmaker Valeant. After the close of trading...
16.01.2017
- Canadian-headquartered, US-managed drugmaker Valeant said it will sell around $2 billion worth of assets as it sets about paring down its staggering debt burden of around $30...
11.01.2017
- On the rebound from its failed drive to acquire Salix Pharmaceuticals from Canadian drugmaker Valeant in November 2016 – Valeant decided to keep the company – Japanese...
01.12.2016
- Talks between Valeant and Takeda about a takeover of Valeant’s Salix subsidiary for $10 billion have broken down amid disagreements over price, among other things, according to the...
